Home   Business   Article

Subscribe Now

52 North Health and University of Cambridge awarded £200,000 to help translate research



More news, no ads

LEARN MORE


52 North Health and the University of Cambridge have been awarded £200,000 under Innovate UK’s Knowledge Transfer Partnership (KTP) programme.

Umaima Ahmad, from 52 North Health. Picture: Keith Heppell
Umaima Ahmad, from 52 North Health. Picture: Keith Heppell

Hauser Forum-based medtech company 52 North Health, which won the Tech for Good Award at the recent Cambridge Independent Science & Technology Awards 2022, is best known for NeutroCheck, the low-cost device used to test for suspected neutropenic sepsis

at home.

The KTP programme, founded in 1975, aims to connect forward-thinking businesses with the UK world-class knowledge bases to deliver business-led innovation projects for growth.

The award will primarily fund the creation of a new post for an immunoassay scientist for 2.5 years, who will develop and validate novel antibodies to create the next generation of low-cost rapid diagnostic solutions. This KTP also includes a bespoke residential training programme.

Dr Pietro Sormanni, group leader at the Department of Chemistry, University of Cambridge, said: “From an academic standpoint, this partnership represents the unique opportunity to translate the fundamental research we carry out into clinical reality, with the potential to greatly improve the healthcare journey of many patients.”

52 North Health recently raised £1m to progress its NeutroCheck device and app.



This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More